US-based Wasatch Advisors buys stakes in Dr Lal PathLabs taking total to 7.04%
US-based Wasatch Advisors Inc on Monday bought 2 per cent stakes in Dr. Lal PatLabs Limited.
Stay updated with breaking news from Lal Pathlab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
US-based Wasatch Advisors Inc on Monday bought 2 per cent stakes in Dr. Lal PatLabs Limited.
Dr Lal Pathlab (DLPL) came out with its quarterly earnings recently; the results were lacklustre.
Indian market surged for the third straight session on Thursday amid positive global cues. Sensex closed 460 points higher at 58,926 and Nifty rose 142 points to end at 17,605.
Its EBITDA witnessed a decline of 21.3% yoy at Rs109 crore in Q3FY22 against Rs139 crore in Q3FY21.
We had covered Dr Lal’s Pathlab in detail a month ago here. Its quarterly earnings report is out and it has also announced acquisition of Suburban Diagnostics.